Synthetic biology fuels bio‑based material revolution with AI‑driven scale‑up

Synthetic biology is reshaping industrial manufacturing by engineering microbes to produce sustainable alternatives to plastics, textiles and building materials. Analysts value the sector at $14 billion, noting that bio‑fabricated materials can be up to 20 % stronger than conventional synthetics while being fully biodegradable. Pilot projects show up to 60 % lower carbon emissions and 35 % reduced post‑processing compared with petrochemical refineries, positioning the technology as a cornerstone of circular‑economy strategies. Researchers project that by 2035 half of specialty chemicals and high‑performance textiles could be produced through these biological methods.

A KAIST research team highlighted the commercial hurdles that keep many biomanufacturing processes in the laboratory “valley of death.” By examining succinic acid and polyhydroxyalkanoate (PHA) as case studies, the team proposed a phased market entry—targeting high‑value sectors such as pharmaceuticals, cosmetics and medical packaging before expanding to broader applications. The study argues that artificial intelligence can accelerate this transition by optimizing microbial design, fermentation processes and economic‑environmental assessments, shortening development cycles and lowering costs.

Together, these developments suggest a near‑term shift toward bio‑based chemical production, driven by both environmental imperatives and AI‑enabled industrialization strategies.